Bone morphogenic proteins 2 and 4 and their receptors in the adult human cornea

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 13, 1998, Pages 2626-2636

  Mohan, Rajiv R ^a,b   Kim, Woo Jung ^a,c   Mohan, Rahul R ^a,b   Chen, Lisha ^a   Wilson, Steven E ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Samsung Advanced Institute of Technology (SAIT)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; MESSENGER RNA; RECEPTOR PROTEIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA CELL; CORNEA ENDOTHELIUM; CORNEA EPITHELIUM; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; CELL COUNT; CELL DIVISION; CELLS, CULTURED; CORNEA; DNA PRIMERS; DNA REPLICATION; DRUG SYNERGISM; FIBROBLASTS; HUMANS; IMMUNOENZYME TECHNIQUES; NF-KAPPA B; PEPTIDES; PRECIPITIN TESTS; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031793266     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Wilson SE, Pedroza L, Beuerman R, Hill JM. Herpes simplex virus type-1 infection of corneal epithelial cells induces apoptosis of the underlying keratocytes. Exp Eye Res. 1997;64:775-779.
2. Wilson SE, He Y-G, Weng J, et al. Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp Eye Res. 1996;62:325-338.
3. Helena MC, Baerveldt F, Kim W-J, Wilson SE. Keratocyte apoptosis following corneal surgery. Invest Ophthalmol Vis Sci. 1998;39: 276-283.
4. Wilson SE, Kim WJ. Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci. 1998;39:220-226.
5. Wilson SE, Li Q, Weng J, et al. The Fas/Fas ligand system and other modulators of apoptosis in the cornea. Invest Ophthalmol Vis Sci. 1996;37:1582-1592.
6. Mohan RR, Lian Q, Kim W-J, Helena MC, Baerveldt F, Wilson SE. Apoptosis in the cornea: further characterization of Fas/Fas ligand system. Exp Eye Res. 1997;65:575-589.
7. Kingsley DM. The TGF-beta superfamily: new members, new receptors and new genetic tests of function in different organisms. Genes Dev. 1994;8:133-146.
8. Kessler D, Melton D. Vertebrate embryonic induction: mesodermal and neural patterning. Science. 1994;266:596-604.
9. Dudley AT, Robertson EJ. Overlapping expression domains of bone morphogenic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev Dynamics. 1997;208:349-362.
10. Hogan BLM. Bone morphogenic proteins: multifunctional regulators of vertebrate development. Genes Dev. 1996;10:1580-1594.
11. Graham A, Francis-West P, Brickell P, Lumsden A. The signalling molecule BMP4 mediates apoptosis in the rhombencephalic neural crest. Nature. 1994;372:684-686.
12. Zou H, Niswander L. Requirement for BMP signaling in interdigital apoptosis and scale formation. Science. 1996;272:738-741.
13. Ito K, Hotta Y. Proliferation pattern of postembryonic neuroblasts in the brain of Drosophila melanogaster. Dev Biol. 1992;149: 134-148.
14. Shah NM, Groves AK, Anderson DJ. Alternative neural crest cell fates are instructively promoted by TGF beta superfamily members. Cell. 1996;85:331-343.
15. Mooy CM, Clark BJ, Lee WR. Posterior axial corneal malformation and uveoretinal angiodysgenesis-a neurocristopathy? Graefes Arch Clin Exp Ophthalmol. 1990;228:9-18.
16. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science. 1988;242: 1528-1534.
17. Oida S, Iimura T, Maruoka Y, Takeda K, Sasaki S. Cloning and sequence of bone morphogenetic protein 4 (BMP-4) from a human placental cDNA library. DNA Seq. 1995;5:273-275.
18. ten Dijke P, Ichijo H, Franzen P, et al. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/ threonine kinase activity. Oncogene. 1993;8:2879-2887.
19. Ide H, Katoh M, Sasaki H, et al. Cloning of human bone morphogenetic protein type IB receptor (BMPR-IB) and its expression in prostate cancer in comparison with other BMPRs. Oncogene. 1997;14:1377-1382.
20. Rosenzweig BL, Imamura T, Okadome T, et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA. 1995;92:7632-7636.
21. Yoshikawa H, Rettig WJ, Lane JM, et al. Immunohistochemical detection of bone morphogenic proteins in bone and soft-tissue sarcomas. Cancer. 1994;74:842-847.
22. Li Q, Weng J, Mohan RR, et al. Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea. Invest Ophthalmol Vis Sci. 1996;37:727-739.
23. Tani M, Glabinski AR, Tuohy VK, Stoler MH, Estes ML, Ransohoff RM. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am J Pathol. 1996;148:889-896.
24. Wilson SE, Walker JW, Chwang EL, He Y-G. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), their receptors, FGF receptor-2, and the cells of the cornea. Invest Ophthalmol Vis Sci. 1993;34:2544-2561.
25. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-alpha-induced cell death. Science. 1996;274:782-784.
26. Kopp E, Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science. 1994;265:956-961.
27. Michel-Salmin LA, Tosi-Couture E, Gautier A, McDowall AW, Dubochet J. Electron microscopy of the chromosomes of Dinoflagellate Porocentrum micans: confirmation of Bouligand's liquid crystal hypothesis. J Ultrastruct Molec Struct Res. 1986;97: 10-30.
28. Lin Y-Z, Yao S, Veach RA, Torgerson TR, Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem. 1995;270:14255-14258.
29. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
30. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376:37-43.
31. Wilson SE, Schultz GS, Chegini N, Weng J, He Y-G. Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res. 1994;59:63-72.
32. Weng J, Mohan RR, Li Q, Wilson SE. IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-1 beta expression in the cornea. Cornea. 1997;16:465-471.
33. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994;12:141-179.
34. Verma IM, Stevenson JK, Schwartz EM, Antwerp DV, Miyamoto S. Rel/NF-kB family:intimate tales of association and dissociation. Genes Dev. 1995;9:2723-2726.
35. Yoshida M, Usui T, Tsujimura K, Inagaki M, Beppu T, Horinouchi S. Biochemical differences between staurosporine-induced apoptosis and premature mitosis. Exp Cell Res. 1997;232:225-239.
36. King KL, Cidlowski JA Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem. 1995;58:175-180.
37. Mohan RR, Kim W-J, Mohan RR, Wilson SE. Active role of transcription factor NF-kB in suppression of TNF alpha-induced apoptosis in corneal fibroblasts [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998;29(4):S1027. Abstract nr 4743.
38. McCarey BE, Napalkov JA, Pippen PA, Koester JM, al Reaves T. Corneal wound healing strength with topical antiinflammatory drugs. Cornea. 1995;14:290-294.
39. Derynck R. TGF-beta-receptor-mediated signaling. Trends Biochem Sci. 1994;19:548-553.
40. Nohno T, Ishikawa T, Saito T, et al. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem. 1995;270:22522-22526.